Transgene SA
TRGNF
$0.70
-$0.89-55.98%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.04% | -8.34% | 0.85% | -158.68% | 1.09% |
| Total Depreciation and Amortization | -3.05% | 13.41% | -0.85% | -20.72% | -1.07% |
| Total Amortization of Deferred Charges | -3.03% | -- | -- | -- | -1.09% |
| Total Other Non-Cash Items | 3.04% | -1,664.09% | -0.79% | 101.28% | 1.09% |
| Change in Net Operating Assets | -3.04% | 585.49% | 0.85% | 4.21% | 1.08% |
| Cash from Operations | 3.04% | 72.37% | 0.85% | -9.87% | 1.09% |
| Capital Expenditure | 3.05% | 45.87% | 0.85% | -59.76% | 1.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.05% | -227.77% | -0.86% | -96.86% | -1.09% |
| Cash from Investing | 3.04% | -24.33% | 0.85% | -108.75% | -1.09% |
| Total Debt Issued | 0.00% | -200.00% | 0.00% | -- | -- |
| Total Debt Repaid | 0.00% | 93.74% | 0.00% | -100.52% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 6,832.17% | 0.00% | -96.88% | 0.00% |
| Cash from Financing | -3.04% | -58.98% | -0.85% | 57.90% | -1.09% |
| Foreign Exchange rate Adjustments | -3.01% | 1.86% | -0.83% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.05% | 498.55% | 0.85% | -102.92% | -1.09% |